ENID NIXON: Open Payments
NPI 1497194930 · JOHNSON CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 76 payments from 19 companies in 2025. Trend: 2023 $2,516 · 2024 $1,856 · 2025 $1,318
Food & beverage: $1,318
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $224 |
| Merck Sharp & Dohme LLC | 8 | $185 |
| Novartis Pharmaceuticals Corporation | 16 | $161 |
| E.R. Squibb & Sons, L.L.C. | 11 | $144 |
| BridgeBio Pharma, Inc. | 6 | $121 |
| Medtronic, Inc. | 1 | $73 |
| Amgen Inc. | 3 | $61 |
| Kestra Medical Technology Services, Inc. | 2 | $60 |
| MEDICOMP INC | 1 | $49 |
| Novo Nordisk Inc | 2 | $43 |
Products named: ELIQUIS, LEQVIO, VERQUVO, Attruby, CAMZYOS, COREVALVE EVOLUT R, REPATHA, Assure WCD.
Industry payments across NY — which companies pay providers there.
